Magnitude of umeclidinium/vilanterol lung function effect depends on monotherapy responses: Results from two randomised controlled trials
Under a Creative Commons license
open access
Keywords
COPD pharmacology
Chronic obstructive pulmonary disease
Bronchodilators
Abbreviations
AE
adverse event
ANCOVA
analysis of covariance
BMI
body mass index
CI
confidence interval
COPD
chronic obstructive pulmonary disease
ECG
electrocardiogram
FEV1
forced expiratory volume in 1 second
FVC
forced vital capacity
GOLD
Global initiative for chronic Obstructive Lung Disease
ITT
intent-to-treat
LS
least squares
LABA
long-acting beta2-agonist
LAMA
long-acting muscarinic antagonist
MCID
minimally clinically important difference
NA
not analysed
SD
standard deviation
SE
standard error
UMEC
umeclidinium
VI
vilanterol
wm
weighted mean
Cited by (0)
Copyright © 2016 The Authors. Published by Elsevier Ltd.